This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bennedbæk, F. N. Articles by Hegedüs, L. Search for Related Content PubMed PubMed Citation Articles by Bennedbæk, F. N. Articles by Hegedüs, L.

Effect of Percutaneous Ethanol Injection Therapy Versus Suppressive Doses of L-Thyroxine on Benign Solitary Solid Cold Thyroid Nodules: A Randomized Trial¹

Department of Endocrinology, Odense University Hospital, DK-5000 Odense C, Denmark

Address all correspondence and requests for reprints to: Finn Noe Bennedbæk, M.D., Department of Endocrinology, Odense University Hospital, DK-5000 Odense C, Denmark.

The results of studies using suppressive doses of L-T₄ on benign solitary solid cold thyroid nodules have been conflicting. Recently, intranodular injection of absolute ethanol has been proposed as an effective treatment, but has been evaluated only in uncontrolled studies. Our objective was to evaluate the effect of two alternative medical treatment modalities, percutaneous ethanol injection therapy and L-T₄, on the benign solitary solid cold thyroid nodule.

In a prospective randomized clinical trial, 50 euthyroid patients with a single solid colloid thyroid nodule causing local discomfort were assigned to a single intranodular injection of sterile 98% ethanol (n = 25) or suppressive doses of L-T₄ (n = 25). We aimed at an ethanol dose of 20–50% of the pretreatment nodular volume. The initial daily dose of L-T₄ was 1.5 µg/kg BW and was adjusted monthly during the first 6 months to reduce serum TSH to subnormal levels (<0.40 mU/L). Thyroid nodule volume and total thyroid volume were assessed by ultrasound, and thyroid function was determined by routine assays before and during follow-up. Symptom scores before and at 12 months were evaluated by a questionnaire rating pressure symptoms and cosmetic symptoms.

The median ethanol dose given was 21% [95% confidence interval (CI), 18;25] of the pretreatment nodule volume. In this group, the median reduction in nodule volume was 47% (CI, 33;57; P < 0.0001) compared to 9% (CI, -7;22; P = 0.09) in the L-T₄ group. The difference between the two treatment regimens was statistically significant (P < 0.0001). The median reduction in perinodular thyroid volume was 20% (CI, 11;31; P = 0.03) in the L-T₄ group, whereas no change was seen in the ethanol group (-2.5%; CI, -18;11; P = 0.9). Fourteen of 25 (56%) patients treated with ethanol injection and 8 of 25 (32%) treated with L-T₄ had complete relief of symptoms at 12 months of follow-up (P = 0.09). No major side-effects were seen in either group.

Percutaneous ethanol injection therapy administered as a single small dose results in a satisfactory clinical response in 50% of patients by halving the nodule volume. The thyroid nodule-reducing effect of L-T₄ suppressive therapy is insignificant, but a subjective satisfactory clinical response is seen in a subgroup of patients, probably explained by the concomitant reduction of perinodular thyroid volume.

This article has been cited by other articles:

				H. Dossing, F. N. Bennedbaek, S. J. Bonnema, P. Grupe, and L. Hegedus Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules Eur. J. Endocrinol., July 1, 2007; 157(1): 95 - 100. [Abstract] [Full Text] [PDF]

				H Dossing, F N Bennedbaek, and L Hegedus Beneficial effect of combined aspiration and interstitial laser therapy in patients with benign cystic thyroid nodules: a pilot study Br. J. Radiol., December 1, 2006; 79(948): 943 - 947. [Abstract] [Full Text] [PDF]

				H. Dossing, F. N. Bennedbaek, and L. Hegedus Effect of ultrasound-guided interstitial laser photocoagulation on benign solitary solid cold thyroid nodules - a randomised study Eur. J. Endocrinol., March 1, 2005; 152(3): 341 - 345. [Abstract] [Full Text] [PDF]

				L. Hegedus, S. J. Bonnema, and F. N. Bennedbaek Management of Simple Nodular Goiter: Current Status and Future Perspectives Endocr. Rev., February 1, 2003; 24(1): 102 - 132. [Abstract] [Full Text] [PDF]

				F. Pacini Role of Percutaneous Ethanol Injection in Management of Nodular Lesions of the Thyroid Gland J. Nucl. Med., February 1, 2003; 44(2): 211 - 212. [Full Text] [PDF]

				H. Dossing, F. N. Bennedbaek, S. Karstrup, and L. Hegedus Benign Solitary Solid Cold Thyroid Nodules: US-guided Interstitial Laser Photocoagulation— Initial Experience Radiology, October 1, 2002; 225(1): 53 - 57. [Abstract] [Full Text] [PDF]

				F. N. Bennedbæk and L. Hegedüs Management of the Solitary Thyroid Nodule: Results of a North American Survey J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2493 - 2498. [Abstract] [Full Text]

				L. Hegedüs, B. Nygaard, and J. M. Hansen Is Routine Thyroxine Treatment to Hinder Postoperative Recurrence of Nontoxic Goiter Justified? J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 756 - 760. [Abstract] [Full Text]

				M. Zingrillo, D. Collura, M. R. Ghiggi, V. Nirchio, and V. Trischitta Treatment of Large Cold Benign Thyroid Nodules Not Eligible for Surgery with Percutaneous Ethanol Injection J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3905 - 3907. [Abstract] [Full Text]

				Approaches to Solitary Thyroid Nodules Journal Watch (General), March 24, 1998; 1998(324): 3 - 3. [Full Text]